Biologic monotherapy in the treatment of rheumatoid arthritis

Código QR

Biologic monotherapy in the treatment of rheumatoid arthritis

Jacqueline Detert, Pascal Klaus Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Berlin, Germany Abstract: Biologics, possibly in combination with a conventional disease-modifying antirheumatic drug (DMARD) – preferabl...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Detert J, Klaus P
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/94ad9370a07342f293587bb13dcb7aa7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Certolizumab Can Also Be Effective in Monotherapy for the Treatment of Rheumatoid Arthritis Patients
por: Santos-Moreno P, et al.
Publicado: (2021)

Infliximab in the treatment of rheumatoid arthritis
por: A Perdriger
Publicado: (2009)

Review of tocilizumab in the treatment of rheumatoid arthritis
por: Yasuaki Okuda
Publicado: (2008)

Biological Therapies for Rheumatoid Arthritis: An Overview for the Clinician
por: Findeisen KE, et al.
Publicado: (2021)

Biological targets in the treatment of rheumatoid arthritis: a comprehensive review of current and in-development biological disease modifying anti-rheumatic drugs
por: Manil Kukar, et al.
Publicado: (2009)

Safety of biologics in rheumatoid arthritis: data from randomized controlled trials and registries
por: Codreanu C, et al.
Publicado: (2015)

B cell reductive therapy with rituximab in the treatment of rheumatoid arthritis
por: Joseph M Tuscano, et al.
Publicado: (2009)

Systematic review and network meta-analysis of combination and monotherapy treatments in disease-modifying antirheumatic drug-experienced patients with rheumatoid arthritis: analysis of American College of Rheumatology criteria scores 20, 50, and 70
por: Orme ME, et al.
Publicado: (2012)

Effect of biologic therapy on radiological progression in rheumatoid arthritis: what does it add to methotrexate?
por: Jones G, et al.
Publicado: (2012)

Non-tumor necrosis factor-based biologic therapies for rheumatoid arthritis: present, future, and insights into pathogenesis
por: Paula FS, et al.
Publicado: (2013)

Rituximab therapy in Greek patients with rheumatoid arthritis
por: Haralampos M Moutsopoulos, et al.
Publicado: (2008)

Effects of 6 months of abatacept treatment on aortic stiffness in patients with rheumatoid arthritis
por: Mathieu S, et al.
Publicado: (2013)

Safety of etanercept in elderly subjects with rheumatoid arthritis
por: Alfredomaria Lurati, et al.
Publicado: (2009)

A critical evaluation of the role of subcutaneous abatacept in the treatment of rheumatoid arthritis: patient considerations
por: Wells AF, et al.
Publicado: (2014)

Effects of rituximab treatment on the serum concentrations of vitamin D and interleukins 2, 6, 7, and 10 in patients with rheumatoid arthritis
por: Hasan E, et al.
Publicado: (2012)

Efficacy and safety of anakinra for the treatment of rheumatoid arthritis: an update of the Oregon Drug&nbsp; Effectiveness Review Project
por: Kylie Thaler, et al.
Publicado: (2009)

IMPACT OF FIBROMYALGIA ON DAS-28 SCORE IN RHEUMATOID ARTHRITIS
por: Ata Ur Rehman, et al.
Publicado: (2018)

Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis
por: Benucci M, et al.
Publicado: (2013)

Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiences
por: Matthew L Stoll, et al.
Publicado: (2008)

Fabrication of a triptolide-loaded and poly-γ-glutamic acid-based amphiphilic nanoparticle for the treatment of rheumatoid arthritis [Corrigendum]
por: Zhang L, et al.
Publicado: (2019)

An Update for the Clinician on Biologics for the Treatment of Psoriatic Arthritis
por: Chimenti MS, et al.
Publicado: (2020)

NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab
por: Re KA, et al.
Publicado: (2012)

&alpha;-Methylprednisolone conjugated cyclodextrin polymer-based nanoparticles for rheumatoid arthritis therapy
por: Jungyeon Hwang, et al.
Publicado: (2008)

Monoclonal antibodies in rheumatoid arthritis: comparative effectiveness of tocilizumab with tumor necrosis factor inhibitors
por: Tanaka T, et al.
Publicado: (2014)

Fabrication of a triptolide-loaded and poly-γ-glutamic acid-based amphiphilic nanoparticle for the treatment of rheumatoid arthritis
por: Zhang L, et al.
Publicado: (2018)

NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab [Corrigendum]
por: Lurati A, et al.
Publicado: (2013)

The Role of Cell Organelles in Rheumatoid Arthritis with Focus on Exosomes
por: Zahra Payandeh, et al.
Publicado: (2021)

Drug usage analysis and health care resources consumption in naïve patients with rheumatoid arthritis
por: Sangiorgi D, et al.
Publicado: (2015)

IL-38 and IL-36 Target Autophagy for Regulating Synoviocyte Proliferation, Migration, and Invasion in Rheumatoid Arthritis
por: Zhe Hao, et al.
Publicado: (2021)

Multifunctional folate receptor-targeting and pH-responsive nanocarriers loaded with methotrexate for treatment of rheumatoid arthritis
por: Zhao J, et al.
Publicado: (2017)

Rheumatoid arthritis hand lesions assessed with outcome measures in rheumatoid arthritis clinical trials-rheumatoid arthritis magnetic resonance imaging score – proposing an extended rheumatoid arthritis magnetic resonance imaging score
por: M. del Carmen Larios-Forte, et al.
Publicado: (2021)

Co-Delivery of Prednisolone and Curcumin in Human Serum Albumin Nanoparticles for Effective Treatment of Rheumatoid Arthritis
por: Yan F, et al.
Publicado: (2019)

Prevention of bone mineral density loss in patients with rheumatoid arthritis treated with anti-TNF&alpha; therapy
por: Hubert Marotte, et al.
Publicado: (2008)

Baricitinib for the treatment of rheumatoid arthritis
por: Ivan Urits, et al.
Publicado: (2020)

High Body Mass Index is Associated with Shorter Retention of Tumor Necrosis Factor-Alpha Blocker Treatment in Rheumatoid Arthritis
por: Elalouf O, et al.
Publicado: (2021)

Rituximab is more effective than second anti-TNF therapy in rheumatoid arthritis patients and previous TNF&alpha; blocker failure
por: Kekow J, et al.
Publicado: (2012)

Cost-effectiveness of routine measuring of serum drug concentrations and anti-drug antibodies in treatment of rheumatoid arthritis patients with TNF-α blockers
por: Laine J, et al.
Publicado: (2016)

Identification of Candidate Genes Related to Synovial Macrophages in Rheumatoid Arthritis by Bioinformatics Analysis
por: Xu J, et al.
Publicado: (2021)

Dynamic Contrast-Enhanced MRI Confirms Rapid And Sustained Improvement Of Rheumatoid Arthritis Induced By Tocilizumab Treatment: An Italian Multicentre Study
por: Cimmino MA, et al.
Publicado: (2020)

Mapping Knowledge Structure and Themes Trends of Osteoporosis in Rheumatoid Arthritis: A Bibliometric Analysis
por: Haiyang Wu, et al.
Publicado: (2021)